Cargando…

The Impact of Tiered-Pricing Framework on Generic Entry in Canada

Background: Generic drug prices have been capped at specified percentages of the interchangeable branded drug’s price by the Canadian provincial public drug plans since 1993. The Pan-Canadian Pharmaceutical Alliance, formed as a coalition by the provinces/territories in Canada, implemented an altern...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Wei, Sun, Huiying, Guh, Daphne P., Lynd, Larry D., Hollis, Aidan, Grootendorst, Paul, Anis, Aslam H.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Kerman University of Medical Sciences 2020
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9309918/ https://www.ncbi.nlm.nih.gov/pubmed/33233033 http://dx.doi.org/10.34172/ijhpm.2020.215

Ejemplares similares

Ontario’s plunging price-caps on generics: deeper dives may drown some drugs
por: Anis, Aslam, et al.
Publicado: (2011)

The impact of generics and generic reference pricing on candesartan and rosuvastatin utilisation, price and expenditure in South Africa
por: de Jager, Henk, et al.
Publicado: (2018)

Development of a tiered framework for public health capacity in Canada
por: Wallar, L.E., et al.
Publicado: (2016)

Health Care Costs Attributable to Prostate Cancer in British Columbia, Canada: A Population-Based Cohort Study
por: Zhang, Wei, et al.
Publicado: (2023)

Price dispersion of generic medications
por: Bernstein, John J. J., et al.
Publicado: (2019)

The Short-Term Impact of Ontario's Generic Pricing Reforms
por: Law, Michael R., et al.
Publicado: (2011)

Impact of Generic Price Linkage System and Reference Price System on prices of pharmaceuticals – comparison of Austria and Finland
por: Martikainen, Jaana E, et al.
Publicado: (2015)

Generic Medicine Pricing Policies in Europe: Current Status and Impact
por: Dylst, Pieter, et al.
Publicado: (2010)

Orphan Drug Pricing and Costs: A Case Study of Kalydeco and Orkambi
por: Hollis, Aidan
Publicado: (2019)

Pharmacy Benefit Manager Pricing and Spread Pricing for High-Utilization Generic Drugs
por: Mattingly, T. Joseph, et al.
Publicado: (2023)

Comparison of tiered formularies and reference pricing policies: a systematic review
por: Morgan, Steve, et al.
Publicado: (2009)

A Generic Quantitative Risk Assessment Framework for the Entry of Bat-Borne Zoonotic Viruses into the European Union
por: Simons, Robin R. L., et al.
Publicado: (2016)

Pharmacy location and medical need: regional evidence from Canada
por: Grootendorst, Paul
Publicado: (2022)

An empirical study of the impact of generic drug competition on drug market prices in China
por: Yina, Chen, et al.
Publicado: (2023)

ENTRY IN THE ADHD DRUGS MARKET: WELFARE IMPACT OF GENERICS AND ME-TOO'S*
por: Bokhari, Farasat A S, et al.
Publicado: (2013)

The pan-Canadian Tiered Pricing Framework and Chinese National Volume-Based Procurement: A comparative study using Donabedian’s structure-process-outcome framework
por: Wang, Quan, et al.
Publicado: (2023)

Upstream solutions for price-gouging on critical generic medicines
por: Houston, Adam R., et al.
Publicado: (2016)

Could international compulsory licensing reconcile tiered pricing of pharmaceuticals with the right to health?
por: Ooms, Gorik, et al.
Publicado: (2014)

Value-based tiered pricing for universal health coverage: an idea worth revisiting
por: Chalkidou, Kalipso, et al.
Publicado: (2020)

The impact of reference pricing and extension of generic substitution on the daily cost of antipsychotic medication in Finland
por: Koskinen, Hanna, et al.
Publicado: (2014)

Price and reimbursement for orphan medicines and managed entry agreements: does Italy need a framework?
por: Jommi, Claudio, et al.
Publicado: (2021)

Costs of early spondyloarthritis: estimates from the first 3 years of the DESIR cohort
por: Harvard, Stephanie, et al.
Publicado: (2016)

Access criteria for anti-TNF agents in spondyloarthritis: influence on comparative 1-year cost-effectiveness estimates
por: Harvard, Stephanie, et al.
Publicado: (2017)

Assessing pricing and reimbursement policies for generic pharmaceuticals in the MENA region for improved efficiency, affordability and generic penetration
por: Kamphuis, Bregtje W., et al.
Publicado: (2021)

A tier-upon-tier march towards the impact factor
por: Martelletti, Paolo
Publicado: (2008)

Association of Generic Competition With Price Decreases in Physician-Administered Drugs and Estimated Price Decreases for Biosimilar Competition
por: Dickson, Sean R., et al.
Publicado: (2021)

The incidence of co-morbidities related to obesity and overweight: A systematic review and meta-analysis
por: Guh, Daphne P, et al.
Publicado: (2009)

Estimating the clinical cost of drug development for orphan versus non-orphan drugs
por: Jayasundara, Kavisha, et al.
Publicado: (2019)

Interrupted time-series analysis of the impact of generic market entry of antineoplastic products in China
por: Guan, Xiaodong, et al.
Publicado: (2018)

Lessons from 20 years of medical cannabis use in Canada
por: Shim, Minsup, et al.
Publicado: (2023)

Thermomass Theory in the Framework of GENERIC
por: Nie, Ben-Dian, et al.
Publicado: (2020)

Get Rich Quick With Old Generic Drugs! The Pyrimethamine Pricing Scandal
por: Gallant, Joel
Publicado: (2015)

Rapid reductions in prices for generic sofosbuvir and daclatasvir to treat hepatitis C
por: Hill, Andrew, et al.
Publicado: (2016)

The long-term effect of generic price competition on the Hungarian statin market
por: Répásy, Balázs, et al.
Publicado: (2023)

The effect of generic market entry on antibiotic prescriptions in the United States
por: Kållberg, Cecilia, et al.
Publicado: (2021)

Modeling HIV/AIDS Drug Price Determinants in Brazil: Is Generic Competition a Myth?
por: Meiners, Constance, et al.
Publicado: (2011)

The timing of 30‐month stay expirations and generic entry: A cohort study of first generics, 2013–2020
por: Kannappan, Sunand, et al.
Publicado: (2021)

Potential impact of subsequent entry biologics in nephrology practice in Canada
por: Martinusen, Daniel J, et al.
Publicado: (2014)

Introduction of generic substitution and reference pricing in Ireland: early effects on state pharmaceutical expenditure and generic penetration, and associated success factors
por: Spillane, Susan, et al.
Publicado: (2015)

Influence of generic reference pricing on medicine cost in Slovenia: a retrospective study
por: Marđetko, Nika, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_7cjqu8c08lavpkevp0gcl1kahe